Patient, X .
HRN: 22-19-50 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/13/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/13/2022
11/20/2022
IV
1.5
Q6
Avulsed Wound Frontal Area
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes